Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Invested Capital (2019 - 2026)

TransMedics has reported Return on Invested Capital over the past 7 years, most recently at 0.05% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 5.0% year-over-year to 0.05%; the TTM value through Dec 2025 reached 0.05%, up 5.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.05% at TransMedics, up from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.05% in Q4 2025 and troughed at 0.01% in Q2 2022.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Invested Capital.
  • Biggest five-year swings in Return on Invested Capital: changed 0bps in 2021 and later grew 5bps in 2025.
  • Year by year, Return on Invested Capital stood at 0.0% in 2021, then surged by 58bps to 0.0% in 2022, then fell by -21bps to 0.0% in 2023, then skyrocketed by 166bps to 0.0% in 2024, then skyrocketed by 3434bps to 0.05% in 2025.
  • Business Quant data shows Return on Invested Capital for TMDX at 0.05% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.